National Health Investors, Inc.
NHI
$71.67
$0.210.29%
| Weiss Ratings | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.61 | |||
| Price History | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.50% | |||
| 30-Day Total Return | 1.81% | |||
| 60-Day Total Return | 7.18% | |||
| 90-Day Total Return | -4.43% | |||
| Year to Date Total Return | 6.08% | |||
| 1-Year Total Return | 29.05% | |||
| 2-Year Total Return | 58.76% | |||
| 3-Year Total Return | 53.10% | |||
| 5-Year Total Return | 74.52% | |||
| 52-Week High % Change | -17.03% | |||
| 52-Week Low % Change | 23.63% | |||
| Price | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $86.13 | |||
| 52-Week Low Price | $57.80 | |||
| 52-Week Low Price (Date) | Apr 10, 2024 | |||
| 52-Week High Price (Date) | Sep 16, 2024 | |||
| Valuation | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.26B | |||
| Enterprise Value | 4.41B | |||
| Price/Earnings (TTM) | 22.88 | |||
| Earnings Per Share (TTM) | 3.12 | |||
| Earnings Per Share Growth | 0.09% | |||
| Price/Earnings To Growth | 286.01 | |||
| Price/Sales (TTM) | 9.68 | |||
| Price/Book (Q) | 2.39 | |||
| Enterprise Value/Revenue (TTM) | 13.13 | |||
| Price | $71.67 | |||
| Enterprise Value/EBITDA (TTM) | 16.96 | |||
| Enterprise Value/EBIT | 23.38 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 45.44M | |||
| Dividend Yield | 5.04% | |||
| Div. Per Share (Most Recent) | $0.90 | |||
| Dividend Per Share (TTM) | $3.60 | |||
| Payout Ratio (TTM) | 113.43% | |||
| Dividend Per Share (Most Recent) | $0.90 | |||
| Company Info | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 615 890 9100 | |||
| Address | 222 Robert Rose Drive Murfreesboro, TN 37129-6346 | |||
| Website | www.nhireit.com | |||
| Country | United States | |||
| Year Founded | 1991 | |||
| Profitability | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 56.16% | |||
| Profit Margin | 41.11% | |||
| Management Effectiveness | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.62% | |||
| Return on Equity | 10.28% | |||
| Income Statement | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 257.05M | |||
| Total Revenue (TTM) | 335.58M | |||
| Revenue Per Share | $7.39 | |||
| Gross Profit (TTM) | 324.00M | |||
| EBITDA (TTM) | 259.92M | |||
| EBIT (TTM) | 188.48M | |||
| Net Income (TTM) | 137.99M | |||
| Net Income Avl. to Common (TTM) | 137.99M | |||
| Total Revenue Growth (Q YOY) | 7.17% | |||
| Earnings Growth (Q YOY) | 34.89% | |||
| EPS Diluted (TTM) | 3.12 | |||
| EPS Diluted Growth (Q YOY) | 29.13% | |||
| Balance Sheet | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 24.29M | |||
| Cash Per Share (Q) | $0.53 | |||
| Total Current Assets (Q) | 126.32M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.39B | |||
| Current Ratio (Q) | 0.312 | |||
| Book Value Per Share (Q) | $29.91 | |||
| Total Assets (Q) | 2.61B | |||
| Total Current Liabilities (Q) | 404.69M | |||
| Total Debt (Q) | 1.15B | |||
| Total Liabilities (Q) | 1.23B | |||
| Total Common Equity (Q) | 1.37B | |||
| Cash Flow | NHI - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -192.32M | |||
| Cash from Financing (TTM) | -13.57M | |||
| Net Change in Cash (TTM) | 1.89M | |||
| Levered Free Cash Flow (TTM) | 168.00M | |||
| Cash from Operations (TTM) | 207.77M | |||
